Jacobs Levy Equity Management, Inc Galera Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $8.28 $254,539 - $1.66 Million	-200,425 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.04 - $10.49 $36,643 - $54,600	5,205 Added 2.67%	200,425 $1.62 Million
Q2 2021 Aug 16, 2021	BUY	$6.08 - $10.44 $692,803 - $1.19 Million	113,948 Added 140.21%	195,220 $1.92 Million
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $386,655 - $573,731	46,306 Added 132.43%	81,272 $717,000
Q4 2020 Feb 16, 2021	SELL	$8.02 - $12.81 $497 - $794	-62 Reduced 0.18%	34,966 $358,000

Q3 2020 Nov 16, 2020	SELL	$6.96 - $9.12 $7,885 - $10,332	-1,133 Reduced 3.13%	35,028 $317,000
Q2 2020 Aug 17, 2020	BUY	$7.14 - $14.41 $258,189 - $521,080	36,161 New	36,161 $258,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.